PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $358,874 | +398.4% | 96,993 | -0.0% | 0.01% | +600.0% |
Q3 2022 | $72,000 | -5.3% | 97,019 | -0.8% | 0.00% | 0.0% |
Q2 2022 | $76,000 | -14.6% | 97,827 | -0.0% | 0.00% | 0.0% |
Q1 2022 | $89,000 | -99.2% | 97,851 | -92.9% | 0.00% | -98.4% |
Q4 2021 | $11,047,000 | +14.5% | 1,379,123 | +19.6% | 0.06% | +26.0% |
Q3 2021 | $9,650,000 | +176.0% | 1,152,912 | +122.3% | 0.05% | +194.1% |
Q2 2021 | $3,496,000 | – | 518,733 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |